{\rtf1\ansi\ansicpg1252\uc1\deff0
{\fonttbl{\f0\fmodern\fcharset0\fprq2 SourceSerifPro-Regular;}}
{\colortbl;\red0\green0\blue0;\red255\green255\blue255;\red128\green128\blue128;}
\paperw12240\paperh15840\margl1800\margr1800\margt1440\margb1440\f0\fs24\cf0\pgnrestart\pgnstarts1
\pard\plain \tx0\tx380\tx720\tx1080\tx1440\tx1800\tx2160\tx2880\tx3600\tx4320\ri340\sa160\sb120\sl276\slmult1\qj\ltrch\loch {\field{\*\fldinst HYPERLINK "scrivlnk://B6EE2491-5153-498D-B450-D4FFA5EF10D6"}{\fldrslt\f0\fs24\b0\i0 scriv_FTLD-pathology-genetics-clinical-integration}}
\par\plain {\f0\fs24\b0\i0 \{ | Greaves, & Rohrer, 2019 | | |zu:7172713:ES22VS97\}}
\par\plain {\f0\fs24\b0\i0 The landscape of the frontotemporal dementia spectrum disorders. About 70% is sporadic with approximately equal numbers of TDP-43 proteinopathies and tauopathies (including corticoba- sal degeneration, CBD progressive supranuclear palsy, PSP Pick\loch\af0\hich\af0\dbch\af0\uc1\u8217\'92s disease, GGT globular glial tauopathy), and a smaller number of FUSopathies (including atypical frontotemporal lobar degeneration with ubiquitin inclusions, aFTLDU). About 30% is genetic with TDP- 43 proteinopathies being the commonest cause (mutations in C9orf72 (usually TDP-43 types A or B), GRN (type A), TBK1 (types A or B), VCP (type D), SQSTM1, and TARDBP) then tauopathies (mutations in MAPT), FUSopathies (mu other proteinopa- thies (mutations in CHMP2B)}
\par\plain \f0\fs24\b0\i0}